From oncology and rheumatoid arthritis to psoriasis management, new targeted immunotherapy options are rapidly shifting the treatment landscape and outcomes for Canadians. This growth also represents an emerging opportunity for community pharmacies to be involved significantly in the patient care journey. This session will explore new therapies available for moderate to severe psoriasis. We will also explore the pharmacist’s role in developing patient-centred specialty service solutions, including coordination of care across the patient journey, as well assessing new revenue opportunities in a post-COVID19 environment.